Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05673252 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CERvical Cancer The InFlammatory Index (CERTIFIKO)

Study acronym: CERTIFIKO
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date changed from estimate of Nov 18, 2024 to Dec 18, 2025v3 Show 4 more changesShow less
    • Start date: Nov 18, 2022 to Jul 18, 2023
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Nov 18, 2024 to Nov 18, 2027
    • Site details revised
  2. Notable Primary completion date: Nov 18, 2023 to Nov 18, 2024v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Although significant advances in screening and treatment , cervical cancer is the fifth most common female cancer in Europe. Major prognostic factors for oncological outcome are used to categorise patients at high, intermediate and low risk groups and to define the type of radical hysterectomy according "Querleu-Morrow classification". The goal of this prospective observational study is to evaluate the association between several inflammatory markers and risk groups according European guidelines in women with cervical cancer Human Papillomavirus (HPV)-associated, in order to optimize the treatment.
Trial Details
NCT Number NCT05673252
Lead Sponsor University of Campania Luigi Vanvitelli
Conditions
(from sponsor)
Cervical Cancer
Related terms Uterine Cervical Neoplasms
Enrollment 128 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov